Other symptoms, such as dysgeusia or aversion to sweet solutions and high-calorie foods can also happen in approximately 11.5% of people under GLP-1RAs treatment (161)
2.3 Role of taste receptors in the gastrointestinal hormone secretion Although, we commonly associate TRCs and TASR only to the oral cavity, they are also localized in extra-oral tissues, including the gastrointestinal tract, where they participate in energy homeostasis by modulating enteroendocrine hormone release (GLP-1, GIP, CCK, PYY) and nutrient sensing, thereby influencing gastric emptying and metabolic adjustments (e.g., glycemia) (59, 60)
Bone density loss: While studies are still ongoing as to GLP-1s effect on bone health, bone mineral density could decrease with diet-induced weight loss 8 If your GLP-1 journey has led to any of these adverse effects, we offer support for digestive comfort, filling nutritional gaps, sustained energy, lean muscle building and bone strengthening
They are listed here as a reference for researchers investigating Retatrutide GLP-3